Biotest AG
XETRA:BIO2

Watchlist Manager
Biotest AG Logo
Biotest AG
XETRA:BIO2
Watchlist
Price: 43.02 EUR Market Closed
Market Cap: 1.7B EUR

Wall Street
Price Targets

BIO2 Price Targets Summary
Biotest AG

There are no price targets for BIO2.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Biotest AG Competitors:
Price Targets
ENTA
Enanta Pharmaceuticals Inc
26% Upside
PTGX
Protagonist Therapeutics Inc
8% Upside
IMDX
Insight Molecular Diagnostics Inc
32% Upside
DVYSR
Devyser Diagnostics AB
49% Upside
87S
Roivant Sciences Ltd
15% Upside
4593
Healios KK
116% Upside
ACAD
ACADIA Pharmaceuticals Inc
10% Upside
NRIX
Nurix Therapeutics Inc
50% Upside

Revenue
Forecast

Revenue Estimate
Biotest AG

For the last 8 years the compound annual growth rate for Biotest AG's revenue is 7%. The projected CAGR for the next 1 year is -1%.

7%
Past Growth
-1%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Biotest AG

For the last 8 years the compound annual growth rate for Biotest AG's operating income is 12%. The projected CAGR for the next 1 year is 25%.

12%
Past Growth
25%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Biotest AG

The compound annual growth rate of Biotest AG's net income for the next 1 year is 121%.

N/A
Past Growth
121%
Estimated Growth
Estimates Accuracy
1%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIO2's stock price target?
Not Available

BIO2 doesn't have any price targets made by Wall Street professionals.

What is Biotest AG's Revenue forecast?
Projected CAGR
-1%

For the last 8 years the compound annual growth rate for Biotest AG's revenue is 7%. The projected CAGR for the next 1 year is -1%.

What is Biotest AG's Operating Income forecast?
Projected CAGR
25%

For the last 8 years the compound annual growth rate for Biotest AG's operating income is 12%. The projected CAGR for the next 1 year is 25%.

What is Biotest AG's Net Income forecast?
Projected CAGR
121%

The compound annual growth rate of Biotest AG's net income for the next 1 year is 121%.

Back to Top